| CONQUER- Biorepository Coordinator Center |
Assassi |
Scleroderma Research Foundation |
| Interferon Regulatory Factor 7 Links Interferon Pathway Activation to the Exaggerates Fibrotic Response in Systemic Sclerosis |
Assassi |
NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases(NIAMS) |
| Comprehensive Molecular Profiling of Longitudinal Skin Samples in Systemic Sclerosis |
Assassi |
AbbVie Inc |
| Determining the Role of Somatic Mutations in Scleroderma |
Assassi |
Scleroderma Research Foundation |
| Genetics versus Environment in Scleroderma Outcome Study (GENISOS), AND Idiopathic Pulmonary Fibrosis-Associated Genetic Susceptibility Loci Predict Scleroderma Interstitial Lung Disease Endophenotypes and Outcomes. |
Mayes |
NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases(NIAMS) |
| Pathogenic effects of DNASE1L3 R206C polymorphism in systemic sclerosis |
Skaug |
NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases(NIAMS) / Rheumatology Research Foundation |
| Pulmonary arterial hypertension susceptibility in systemic sclerosis patients with the DNASE1L3 R206C variant |
Skaug |
NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases(NIAMS) |
| MYORISE – Myositis Registry for Investigation, Surveillance, and Evidence |
Tiniakou |
Division Funded |